Home Infusion Therapy Market Size is Surpassing USD 88.61 Billion by 2033, Growing at Projected 9.2% CAGR
The home infusion therapy market has been experiencing significant growth due to the increasing preference for at-home healthcare and advancements in medical technology. The market is also supported by the increasing adoption of home healthcare services and a shift towards patient-centered care models.
Newark, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The home infusion therapy market is poised for substantial expansion as the demand for at-home healthcare solutions increases. Driven by advancements in medical technology and a growing preference for home-based care, this market is experiencing robust growth. The report published by The Brainy Insights shows that the global home infusion therapy market is expected to grow from USD 36.75 billion in 2023 to USD 88.61 billion by 2033, at a CAGR of 9.2% during the forecast period 2024 - 2033. North America emerged as the most significant global home infusion therapy market, with a 55% market revenue share in 2023.
Get a Free Sample Research Report: https://www.thebrainyinsights.com/enquiry/sample-request/13716
The home healthcare segment of the market has development prospects due to adequate insurance coverage for home infusion. Several firms, like Option Care Enterprises, CHI Health, and others, offer infusion therapy services in home healthcare settings, and the cost is paid by insurance. Smiths Medical and Ivenix, Inc. signed a collaboration agreement in May 2021 to deliver a comprehensive suite of infusion management solutions in the US market. This collaboration is projected to increase patient safety through evolving infusion management. Such collaborations are projected to boost market expansion in this region.
Leading companies in the industry include CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, and JMS Co. Ltd. among others, offer more significant opportunities and continuously focus on new product developments and venture capital investments to obtain market share.
Report Scope and Segmentation –
| Report Coverage | Details |
| Forecast Period | 2024-2033 |
| Forecast CAGR | 9.2% |
| 2033 Value Projection | USD 88.61 Billion |
| Market Size in 2023 | USD 36.75 Billion |
| Historical Data | 2020-2022 |
| No. of Pages | 238 |
| Report Coverage | Revenue Forecast, Company Profiles, Competitive Landscape, Growth Factors and Latest Trends |
| Segments Covered | Product, Application, Regions |
| Regions Covered | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
| Home Infusion Therapy Market Growth Drivers | Rising Prevalence of Chronic Diseases |
Browse Detailed Summary of Research Report with TOC: https://www.thebrainyinsights.com/report/home-infusion-therapy-market-13716